drugset / Trial / NCT06902103
Pharmacokinetic Study of Single and Multiple Intravenous Administration of Nalbuphine Hydrochloride Injection in Healthy Chinese Volunteers
Phase 1
Completed
22 enrolled
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd
RandomizedParallel-groupSingle-blindBasic science
Summary
Objective：To evaluate the pharmacokinetic characteristics and safety of single and multiple intravenous injections of nalbuphine hydrochloride injection in healthy subjects.
Timeline
- Start
- 2023-12-20
- Primary completion
- 2023-12-26
- Completion
- 2024-01-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nalbuphine | Small molecule | — | Intravenous |
Indications
No indication recorded.